콜린분해효소억제제 사용 중지 후 발생한 불연속증후군 2예 = Two Cases of Discontinuation Syndrome Following Cessation of Cholinesterase Inhibitors

다국어 초록 (Multilingual Abstract)

Discontinuation syndrome is a cluster of symptoms that appear when a patient terminates long-term medication. We report 2 patients with Alzheimer's disease who developed significant behavioral disturbances after the cessation of cholinesterase inhibitors. Although the clinical profile of discontinuation syndrome in cholinesterase inhibitors are yet poorly defined, it may be of importance to consider this syndrome when patients develop significant behavioral disturbances after these agents are stopped, and if more severe reactions are expected, retrial of these agents may be prudent.

참고문헌 (Reference)

1 "phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer's disease" multicenter 427-433, 2001

2 "double-blind study of donepezil in moderate to severe Alzheimer's disease" 613-620, neurology2001

3 "The effect of rivastigmine on sleep in elderly healthy subjects" 25 : 243-249, 2000

4 "The association of serum anticholinergic activity with delirium in elderly medical patients" 6 : 31-41, 1998

5 "Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition" 7-, 1997

6 "Selective serotonin reuptake inhibitor discontinuation syndrome:proposed diagnostic criteria" 25 : 255-261, 2000

7 "Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease" 45 (45): 15-22, 1999

8 "Donepezil improves symptoms of delirium in dementia:implications for future research" 11 : 159-161, 1998

9 "Discontinuation syndrome following donepezil cessation" 18 : 282-284, 2003

10 "A 52-week study of the efficacy of rivastigmine in patients with mild-to-moderately severe Alzheimer's disease" 44 : 236-241, 2000